Platform — Allen Biotechnology Co

The platform

Three integrated capabilities. One discovery engine.

Structure prediction, high-throughput screening, and manufacturing science aren't separate vendors here — they're one connected pipeline, built to compound learnings across every program.

Capability 01

Structure prediction

Our models predict full 3D conformations for candidate proteins and score binding affinity, stability, and expressibility before synthesis — cutting the design-build-test loop from months to days.

  • → Physics-informed folding models trained on proprietary structural data
  • → In-silico affinity maturation across millions of variants
  • → Automated developability scoring at the design stage
Capability 02

High-throughput screening

Automated liquid-handling arrays test thousands of variants per week for binding, thermal stability, and functional activity, feeding results straight back into the design models.

  • → 96- and 384-well automated assay pipelines
  • → Real-time data feedback into the design loop
  • → Orthogonal validation across three independent assay classes
Capability 03

Manufacturing & scale-up

Candidates that clear developability triage move directly into process development with our manufacturing partners — no redesign, no lost time.

  • → Cell-line development and titer optimization
  • → GMP-ready process transfer packages
  • → Formulation and stability studies

Engagement models

Work with us the way that fits your program

Feasibility sprint

A scoped four-week computational assessment to test whether a target is tractable for our platform.

Co-development

Joint discovery programs under a shared milestone and IP framework, from design through IND-enabling studies.

Platform license

License our structure-prediction and screening tools directly into your own discovery organization.

Let's scope your program

Tell us about your target biology and we'll recommend the right engagement model.